Treatment of chronic diabetic lower extremity ulcers with advanced therapies: a prospective, randomised, controlled, multi‐centre comparative study examining clinical efficacy and cost

Advanced therapies such as bioengineered skin substitutes ( BSS ) and dehydrated human amnion/chorion membrane ( dHACM ) have been shown to promote healing of chronic diabetic ulcers. An interim analysis of data from 60 patients enrolled in a prospective, randomised, controlled, parallel group, multi‐centre clinical trial showed that dHACM ( EpiFix ®, MiMedx Group Inc., Marietta, GA ) is superior to standard wound care ( SWC ) and BSS...